Citations

Clear

32 citation(s) found for "Rosenwald, Andreas".

MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN‐FIXED, PARAFFIN‐EMBEDDED TISSUE SPECIMENS – AN LLMPP PROJECT
Rosenwald, Andreas , Ott, German , Ramsower, Colleen , Braziel, Rita M., Weisenburger, Dennis D. , Chan, John, Cook, James R. , Fu, Kai , Greiner, Timothy C. , Smeland, Erlend B., Glinsmann‐Gibson, Betty, Gascoyne, Randy D. , Staudt, Louis M. , Mottok, Anja , Wright, George W. , Campo, Elı́as , Delabie, Jan , Song, Joo Y. , Chan, J.W., Holte, Harald , Jaffe, Elaine S. , Connors, Joseph M. , Scott, David W. , Steidl, Christian , Rimsza, Lisa M.

Mayo Clinic

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 59-60

10.1002/hon.2437_46 Get It

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
Jurinović, Vindi , Kridel, Robert , Szczepanowski, Monika , Horn, Heike , Dreyling, Martin , Rosenwald, Andreas , Ott, German , Klapper, Wolfram , Friedberg, Jonathan W. , Ansell, Stephen M. , Gascoyne, Randy D. , Unterhalt, Michael, Weinstock, David M. , Weigert, Oliver , Kridel, Robert , Staiger, Annette M. , Klapper, Wolfram , Zelenetz, Andrew D. , Barr, Paul M. , Sehn, Laurie H. , Connors, Joseph M.

Mayo Clinic

Blood | July 14, 2016 | Volume: 128 | Issue: 8 | Pages: 1112-1120

10.1182/blood-2016-05-717355 | PMID 27418643 Get It

Key Points The posttreatment end point progression of FL within 24 months (POD24) is strongly associated with OS. A pretreatment clinicogenetic risk model (m7-FLIPI) predicts POD24 and OS and identifies the smallest subgroup with highest unmet need.